Related Experiment Video
Updated: Jun 16, 2026
10:27
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Five steps for structural reform in clinical cancer research
1amathesonresearch@gmail.com
American Journal of Public Health
|February 20, 2010
Summary
Clinical cancer research faces challenges despite advances. Optimizing research structures and collaboration among government, industry, and academia is crucial for future treatment breakthroughs.
Area of Science:
- Oncology
- Clinical Research
- Medical Innovation
Background:
- Despite progress in cancer prevention, early detection, and treatment, clinical research has not matched the impact of earlier breakthroughs like imatinib.
- Significant scientific hurdles and structural inefficiencies impede research progress.
- Current research organization, regulation, and conduct require optimization.
Purpose of the Study:
- To identify key impediments in clinical cancer research.
- To propose necessary adjustments in the roles of various stakeholders to optimize the research environment.
- To outline a strategy for enhancing research efficiency and maximizing funding benefits.
Main Methods:
- Analysis of existing clinical research structures and their deficiencies.
- Review of the roles and interactions of government, industry, academia, and regulatory bodies.
- Synthesis of potential reforms and their enabling characteristics.
Main Results:
- Identified scientific and structural deficiencies as primary barriers to progress.
- Highlighted the need for coordinated adjustments in stakeholder roles.
- Proposed that enabling reforms, building on existing expertise, can yield substantial progress.
Conclusions:
- Optimizing the clinical cancer research environment requires systemic adjustments.
- Collaboration and redefined roles among government, industry, academia, and regulatory authorities are essential.
- Targeted, enabling reforms can significantly advance cancer treatment development without radical intervention.
More Related Videos
Related Concept Videos
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:16Clinical Trials
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
01:28Preclinical Development: Overview
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.